• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

342.680 USD 0.360 0.10%

As of 20:10:00 ET on 09/02/2014.

Company Profile for Biogen Idec Inc (BIIB)

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

Contact Information

Biogen Idec Inc

225 Binney Street
Cambridge, MA 02142
United States
Phone: 781-464-2000

Key Executives for Biogen Idec Inc (BIIB)

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
Stuart A Kingsley "Tony"Exec VP:Global Commercial OpsKenneth A DipietroExec VP:Human Resources
John G CoxExec VP:PharmaceuticalAlfred W Sandrock JrSenior VP/Chief Medical Ofcr
Spyros Artavanis-TsakonasSenior VP/Chief Scientific OfcrGregory F CovinoVP:Finance/Chief Acctg Officer
Claudine ProwseVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil